ClinicalTrials.gg
Active, not recruitingNCT07905716Updated Nov 3, 2026

Comparative Effects of Sensorimotor Training and tACS on Upper Limb Function and Cervical Proprioception in Subacute Stroke

An interventional study of sensorimotor training with TACS and sensorimotor training with Sham TACS in Sub-acute Stroke, sponsored by University of Management and Technology Lahore. Active, not recruiting at 1 site in Pakistan. Open to participants aged 45 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-11-03.

Sponsored by University of Management and Technology Lahore · Not applicable, Interventional, and Treatment

Updated Nov 3, 2026Eligibility revisedNewly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
38
Allocation
Randomized
Ages
45 Years to 60 Years
Sex
All
01

Study summary

Stroke is leading cause of death and disability worldwide, resulting in significant functional limitations and disabilities experienced by stroke survivors. Stroke is an umbrella term that includes disorders such as cerebral infarction, cerebral hemorrhage, and subarachnoid hemorrhage.The aim of this study will be to compare the effects of sensorimotor training and transcranial alternating current stimulation on upper extremity functions, sensorimotor impairment and cervical joint position sense in sub-acute stroke patients.

A single blinded randomized clinical trial will be used. Allocation will be concealed by sealed envelope. Non- probability convenient sampling will be done. On the basis of inclusion criteria participants will be randomly allocate in two groups (Group A and Group B) by using computer-generated software. Group A will receive sensorimotor training for 40 mins and TACS for 20 minutes at 2mA current, for 5 days/week for 4 weeks. Group B will receive sensorimotor training for 40 minutes and sham TACS for 20 minutes per session , for 5 days/week for 4 weeks . Measurements will be taken at baseline and at 4th week. Data will be collected using Fugyl meyer assessment scale, cervical joint position error test and revised Nottingham sensory assessment scale. Data analysis will be done by SPSS software version 27. The statistical software IBM SPSS Statistics SPSS 27 will be used for calculations. After assessing the normality by Shapiro-wilk test, if the p value is greater than 0.05 the data will be distributed normally, so parametric test will be applied. If p value is less than 0.05 than non-parametric test will be applied.

02

Conditions studied

  • Sub-acute Stroke

Browse trials for

Keywords

  • Sensorimotor training
  • sensorimotor impairment
  • cervical joint position
  • transcranial Alternating current stimulation
  • stroke
03

In context

Stroke

8,255 studies on the registry are indexed under Stroke; 2,056 are open to participants now.

This study's enrollment of 38 is below the median of 49 across 6,024 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

University of Management and Technology Lahore is the lead sponsor of 39 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

The criteria were revised on the registry on Nov 3, 2026. See what changed

Ages eligible
45 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients aged 45-60 years old
  • both genders
  • first-ever stroke (ischemic or haemorrhagic) confirmed by CT scan or MRI
  • subacute stage of stroke (1-6 months post stroke)
  • (MMSE) score >24
  • Spasticity less than 2 by modified Ashworth scale (4)
  • National institute of health stroke scale (NIHSS) arm score should be >1
  • Not receiving any other form of physiotherapy for upper limb (5)
  • Able to follow verbal instructions

Exclusion criteria

Exclusion Criteria:

  • Patients will be excluded if they will present with
  • history of seizures or epilepsy
  • presence of implants in the body
  • use of a pacemaker
  • Skin lesions or infection at electrode placement sites
  • Unstable cardiovascular condition
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
38 participants (actual)

Study arms

  • Experimental
    sensorimotor training with TACS

    Group A will receive sensorimotor training for 40 mins and TACS for 20 minutes at 2mA current, for 5 days/week for 4 weeks. Measurements of all the outcome measures will be taken at baseline and at 4th week. Sensorimotor training tasks include texture discrimination, light touch, temperature, pinprick, pressure, Bilateral simultaneous touch, proprioception and task related to stereognosis. tACS will be administered 5 days per week for 4 weeks. After screening exclusion criteria, 25-35 cm² sponge electrodes will be positioned over the affected hemisphere's primary motor cortex (M1; C3/C4) and the contralateral supraorbital area using the 10-20 EEG system. Scalp landmarks will be measured, marked, and cleaned, and hair will be parted to ensure proper electrode contact. Saline-soaked sponge pads or conductive gel will be used, and the electrodes will be secured and connected to the stimulator. Stimulation will be delivered at 2 mA and 10 Hz for 20 minutes, with gradual ramp-up and ramp-

    Other: sensorimotor training with TACS

  • Active comparator
    sensorimotor training with Sham TACS

    tACS will be administered 5 days per week for 4 weeks. After screening exclusion criteria, 25-35 cm² sponge electrodes will be positioned over the affected hemisphere's primary motor cortex (M1; C3/C4) and the contralateral supraorbital area using the 10-20 EEG system. Scalp landmarks will be measured, marked, and cleaned, and hair will be parted to ensure proper electrode contact. Saline-soaked sponge pads or conductive gel will be used, and the electrodes will be secured and connected to the stimulator. Stimulation will be delivered at 2 mA and 10 Hz for 20 minutes, with gradual ramp-up and ramp-down over 15-30 seconds to minimize discomfort

    Other: sensorimotor training with Sham TACS

Interventions

  • Othersensorimotor training with TACS

    Group A will receive sensorimotor training for 40 mins and TACS for 20 minutes at 2mA current, for 5 days/week for 4 weeks. Measurements of all the outcome measures will be taken at baseline and at 4th week. Sensorimotor training tasks include texture discrimination, light touch, temperature, pinprick, pressure, Bilateral simultaneous touch, proprioception and task related to stereognosis. tACS will be administered 5 days per week for 4 weeks. After screening exclusion criteria, 25-35 cm² sponge electrodes will be positioned over the affected hemisphere's primary motor cortex (M1; C3/C4) and the contralateral supraorbital area using the 10-20 EEG system. Scalp landmarks will be measured, marked, and cleaned, and hair will be parted to ensure proper electrode contact. Saline-soaked sponge pads or conductive gel will be used, and the electrodes will be secured and connected to the stimulator.

  • Othersensorimotor training with Sham TACS

    . Sensorimotor training tasks include texture discrimination, light touch, temperature, pinprick, pressure, Bilateral simultaneous touch, proprioception and task related to stereognosis. sensorimotor training for 40 minutes and sham TACS for 20 minutes per session , for 5 days/week for 4 weeks

06

What researchers measure

Primary outcomes

  1. joint position sense through Cervical joint position test

    The Cervical Joint Position Error (JPE) Test is a measurement tool used to clinically assess an individual's cervicocephalic proprioception ability. The patient sits 90 cm from a wall-mounted target and wears a headband with a laser pointer. After recording the neutral starting position, the patient closes their eyes, moves their head in rotation (left/right), flexion, or extension, and returns to the starting position. The test is repeated three times in each direction, and the average repositioning error is calculated. A repositioning error greater than 4.5° (approximately 7 cm) indicates impaired cervical proprioception.

    Time frame: at base line and after 4 weeks

  2. somatosensory impairment through Revised Nottingham Sensory Assessment Scale

    The rNSA examines somatosensory impairment using a 3-point scale (0 =absent, 1 = impaired, 2 = normal) and takes approximately 25-35 min to complete. It consists of 72 items and is grouped into three sub-scales. Tactile Sensation 54 Points \< 54 Points indicates a deficit ,Kinesthesia 12 Point \< 12 Points indicates a deficit., Stereognosis 22 Points \< 19 Points indicates impairment.

    Time frame: at base line and after 4 weeks

  3. Fugyl-Meyer Assessment for upper extremity (FMA-UE)

    Fugyl-Meyer Assessment (FMA) scale is an index to assess sensorimotor impairments who have had stroke. The Fugyl-Meyer Assessment for upper extremity (FMA-UE) has been tested extensively, and is found to have excellent psychometric properties. For upper extremity assessment, Rating is from 0-50 with 0-25 points showing severe impairment and 26-50 points showing moderate impairment.

    Time frame: at base line and after 4 weeks

07

Study locations

1 site
08

References and documents

Publications

  • Li C, Chen Y, Tu S, Lin J, Lin Y, Xu S, Wu M, Xie Y, Jia J. Dual-tDCS combined with sensorimotor training promotes upper limb function in subacute stroke patients: A randomized, double-blinded, sham-controlled study. CNS Neurosci Ther. 2024 Apr;30(4):e14530. doi: 10.1111/cns.14530. Epub 2023 Nov 23. PubMed 37994674 ↗

Individual participant data

Plan to share: Yes — The results data collected , de-identified individual participant data will be shared.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: 6 months after the publication of the manuscript.

Access criteria: The data can be requested from the corresponding author.

09

Updates

2 registry updates since Sep 25, 2026
Eligibility
9 inclusion criteria added, 1 removed; 6 exclusion criteria added, 1 removed
What changed in the criteria
Inclusion criteria
  • RemovedPatients aged 45-60 years old both genders first-ever stroke (ischemic or hemorrhagic) confirmed by CT scan or MRI subacute stage of stroke (1-6 months post stroke) Mini mental state examination (MMSE) score >24 Spasticity less than 2 by modified Ashworth scale (4) National institute of health stroke scale (NIHSS) arm score should be >1 Not receiving any other form of physiotherapy for upper limb (5) Able to follow verbal instructions
  • AddedPatients aged 45-60 years old
  • Addedboth genders
  • Addedfirst-ever stroke (ischemic or haemorrhagic) confirmed by CT scan or MRI
  • Addedsubacute stage of stroke (1-6 months post stroke)
  • AddedMini mental state examination (MMSE) score >24
  • AddedSpasticity less than 2 by modified Ashworth scale (4)
  • AddedNational institute of health stroke scale (NIHSS) arm score should be >1
  • AddedNot receiving any other form of physiotherapy for upper limb (5)
  • AddedAble to follow verbal instructions
Exclusion criteria
  • RemovedPatients will be excluded if they will present with history of seizures or epilepsy presence of implants in the body use of a pacemaker Skin lesions or infection at electrode placement sites Unstable cardiovascular condition
  • AddedPatients will be excluded if they will present with
  • Addedhistory of seizures or epilepsy
  • Addedpresence of implants in the body
  • Addeduse of a pacemaker
  • AddedSkin lesions or infection at electrode placement sites
  • AddedUnstable cardiovascular condition
Nov 3, 2026
Registered
First appeared on the registry
Oct 29, 2026
Show all 2 updates
  1. Nov 3, 2026
    Eligibility 9 inclusion criteria added, 1 removed; 6 exclusion criteria added, 1 removed
    What changed in the criteria
    Inclusion criteria
    • RemovedPatients aged 45-60 years old both genders first-ever stroke (ischemic or hemorrhagic) confirmed by CT scan or MRI subacute stage of stroke (1-6 months post stroke) Mini mental state examination (MMSE) score >24 Spasticity less than 2 by modified Ashworth scale (4) National institute of health stroke scale (NIHSS) arm score should be >1 Not receiving any other form of physiotherapy for upper limb (5) Able to follow verbal instructions
    • AddedPatients aged 45-60 years old
    • Addedboth genders
    • Addedfirst-ever stroke (ischemic or haemorrhagic) confirmed by CT scan or MRI
    • Addedsubacute stage of stroke (1-6 months post stroke)
    • AddedMini mental state examination (MMSE) score >24
    • AddedSpasticity less than 2 by modified Ashworth scale (4)
    • AddedNational institute of health stroke scale (NIHSS) arm score should be >1
    • AddedNot receiving any other form of physiotherapy for upper limb (5)
    • AddedAble to follow verbal instructions
    Exclusion criteria
    • RemovedPatients will be excluded if they will present with history of seizures or epilepsy presence of implants in the body use of a pacemaker Skin lesions or infection at electrode placement sites Unstable cardiovascular condition
    • AddedPatients will be excluded if they will present with
    • Addedhistory of seizures or epilepsy
    • Addedpresence of implants in the body
    • Addeduse of a pacemaker
    • AddedSkin lesions or infection at electrode placement sites
    • AddedUnstable cardiovascular condition
    + 1 other change: verification date
  2. Oct 29, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07905716
Lead sponsor
University of Management and Technology Lahore
Responsible party
Zainab Hassan (Assistant Professor, University of Management and Technology Lahore) — Principal investigator
First posted
Oct 29, 2026
Start date
Oct 22, 2026
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Nov 3, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion